Efficacy and safety of rituximab in a Brazilian cohort of patients with refractory myasthenia gravis
Pedro José Tomaselli(Universidade de São Paulo), Ana Lemos, Lucas Vieira, Wilson Marques(Universidade de São Paulo), Mateus Gustavo Favaro, André Clériston José dos Santos(Universidade de São Paulo), Rodrigo Siqueira Soares Frezatti(Clinics Hospital of Ribeirão Preto), Cláudia Ferreira da Rosa Sobreira(Universidade de São Paulo)
Cited by 0
Related Papers
Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia
|Nature Genetics|2019|592
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
|The Lancet Neurology|2013|441
Mitochondrial encephalomyopathy with coenzyme Q <sub>10</sub> deficiency
|Neurology|1997|196
Alteration of Ganglioside Biosynthesis Responsible for Complex Hereditary Spastic Paraplegia
|The American Journal of Human Genetics|2013|183